Yabao Pharmaceutical Group Co., Ltd (600351.SS) SHH
6.22
-0.16(-2.51%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.51B |
| Enterprise Value | 3.73B |
| P/E Ratio | 13.54 |
| PEG Ratio | 0.37 |
| Price/Sales Ratio | 1.97 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 1.59 |
| Enterprise/EBITDA | 8.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.13 |
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 2.24B |
| Revenue/Share | 3.17 |
| Gross Profit | 1.11B |
| EBITDA | 453.14M |
| Net Income | 320.01M |
| Diluted EPS | 0.46 |
Balance Sheet
| Total Cash | 866.56M |
| Total Cash/Share | 1.25 |
| Total Debt | 36.85M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.92 |
| Book Value Per Share | 4.04 |
Price History
| 52-Week Change | 0.81 |
| 52-Week High | 8.68 |
| 52-Week Low | 5.86 |
| Moving Average 50 Days | 6.64 |
| Moving Average 200 Days | 6.69 |
Statistics
| Average Volume | 18.5M |
| Shares Outstanding | 692M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 8 |
| Payout Ratio | 1.09 |
| Last Split Factor | 2:1 |
| Last Split Date | May 28, 2010 |
